Whether you are healthy or have a medical condition, there are opportunities to participate in a research study. Health research ranges from simple questionnaires or screening tests, to clinical trials of a new drug or device.
The purpose of this study is to determine the relationships among the clinical, cognitive, imaging, genetic and biochemical biomarker characteristics of the entire spectrum of Alzheimer's disease (AD), as the pathology evolves from normal aging through very mild symptoms, to mild cognitive impair
Participants will complete a series of computerized cognitive tests and two health questionnaires. The performance of young stroke patients will be compared to healthy controls for each computerized cognitive test.
The purpose of this study is to determine whether there is a difference between the 3 available MenACWY vaccines in Canada (used against meningococcal infections), and if any one is better than the others.
The purpose of this study is to see whether the loss of a specific substance (called myelin) in the outer part of the brain accounts for poor cognitive function in participants with bipolar disorder as compared to healthy participants.
The purpose of the study is to analyze the effect of moving backgrounds and additional working memory load on smooth pursuit eye movements in individuals with mild traumatic brain injury (mTBI).
The purpose of this study is to collect neurocognitive data from healthy, non-MS, untreated controls to aid in the interpretation of data acquired from treatment trials using both individual neurocognitive test scores and the MS-COG composite score. Cognitive function in healthy controls will be
Recent evidence suggests a connection between the gut and the brain, and that certain conditions in the gut might be associated with neurological diseases. Research suggests that people with Alzheimer's Disease differ from healthy controls with respect to the bacteria (microbiome) present in the
The Clover trial is evaluating an investigational vaccine that may help to prevent Clostridium difficile infection. Participants in the study are adults 50 years of age and older, who are at risk of developing Clostridium difficile infection.